Chitose Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp173 (market cap 176B, 169.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Chitose Internasional Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 169.4K). Which is the better fit depends on your goals.
| CINT | OBAT | |
|---|---|---|
Market Cap | 176B | 164.65B |
Volume | 169.4K | 187.4K |
Lot | 1.69K | 1.87K |
Turnover | 29.86M | 44.35M |
Average Price | 176.25 | 236.67 |
Value | 29.86M | 44.35M |
Indicative Equilibrium Price | — | 242 |
Indicative Equilibrium Volume | — | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →